Navigation Links
Quorum Review IRB Executive Vice-Chair to Speak at DIA’s 49th Annual Meeting
Date:6/13/2013

Seattle, WA (PRWEB) June 13, 2013

Quorum Review IRB, the industry leader in central IRB services, announces its Executive Vice-Chair, Royce A. Morrison, MD, MS, as a presenter and panel chair at the Drug Information Association’s 49th Annual Meeting. This year DIA is held in Boston, MA, June 23-27, 2013.

Dr. Morrison chairs his first session “First-in-Human Studies: How Much Complexity Is Too Much?” on Tuesday, June 25 at 1:45 p.m. The meeting topic includes trends that disrupt standard early-phase sequences and drive study complexity, and the best practices to mitigate risks. Dr. Morrison focuses on “The IRB: Regulatory Protection” in his portion of the presentation. On Wednesday, June 26 at 10:15 a.m., Dr. Morrison chairs the session, “Pharmacometrics: Implications and Impact in Preclinical to Early Phase Clinical Development,” where panelists discuss the discipline of pharmacometrics in drug development and regulatory decision-making. Dr. Morrison will present “Opportunities to Take Advantage of Pharmacometrics” during that session. Later that afternoon at 4:00 p.m., he heads the panel discussion for “Pharmacometric Methods: Essential for Optimal Drug Development Strategy”. This session defines pharmacometrics and describes examples of its application across the range of drug and development and decision-making activities.

Dr. Morrison serves as Executive Vice-Chair on Quorum’s Review Board and is board certified in internal medicine as well as a Certified Physician Investigator by the Academy of Pharmaceutical Physicians and Investigators. He earned his MD degree at Stanford University and has practiced in both private and HMO settings, emphasizing geriatrics and HIV/AIDS. Dr. Morrison has been a member of the Board of Association of Clinical Pharmacology Units, and is Past President and Board member of the Northwest Association for Biomedical Research.

The DIA Annual Meeting is the largest multidisciplinary event that brings together a global network of professionals to foster innovation that will lead to the development of safe and effective medical products and therapies. More information about the 2013 conference is available on the DIA website.

For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.

About Quorum Review IRB

Quorum Review is an independent review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10819470.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Quorum Review IRB Launches Site Enrollment Service
2. Quorum Review IRB Presents “IRB Review of Registries, Databases and Biobanking” at 2013 AAHRPP Conference
3. Quorum Review IRB to Present “eConsent and the iPad: a Case Study” at Global ACRP Conference
4. Quorum Review IRB Presents on Good Clinical Practice Essentials at MAGI’s 2013 Clinical Research Conference
5. Quorum Review’s CEO Presents on IRB Response to Key Changes in Clinical Research Practice
6. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
7. AADR comments on review that validates association between oral health and heart health
8. IUDs Work as Emergency Contraceptive: Review
9. ICU stays for worst asthma drop 74 percent, review finds
10. Antiretroviral treatment for preventing HIV infection: an evidence review for physicians
11. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
Breaking Medicine Technology: